You’re almost registered.
The Life Science industry (consisting of biotech, pharma, med tech, devices, diagnostics and their collaborators) shares many attributes of other industries, but with very long product life cycles and time to revenue, and a highly regulated environment, several things make this industry unique in the challenges faced by its executives and Boards. This peer group seeks to learn from each other in both the commonalities and the nuanced uniqueness.
Who is hosting? Barbara Troupin
Barbara Troupin is a Chief Medical Officer and public-company independent board director and member of the Nomination and Governance Committee for Equillium (NASDAQ:EQ). Over her 20+ years as a life science executive, her roles have spanned Clinical, Medical, Regulatory, Operations and Strategy functional areas, and she has worked at both private and public companies. She has a strong preference for small and emerging companies where she can have a real impact on corporate strategy and external narrative, decision making processes to drive internal clarity and effectiveness, and in setting a work culture which is engaged, empowered, and inclusive. She helps companies scale in a stage appropriate manner focusing on best strategies for value creation. She holds an MD from the University of Pennsylvania and an MBA from the Wharton School of Business. She has been a member of Athena since 2018, been selected for the 2019 Women in Bio Boardroom Ready cohort, and participated in Harvard’s executive education for Women on Life Science Boards.
Who is it for? Anyone interested in discussions surrounding life sciences - Biotech, Pharma, Medical Devices, Diagnostics, MedTech, Tools and Support Organizations, including funders of the life sciences
What you will gain:
What to expect:
Time commitment: 1 hour per month
Date and time: Fourth Friday of each month at 2pmPST/5pmEST
Barbara Troupin is a Chief Medical Officer and public-company independent board director and member of the Nomination and Governance Committee for Equillium (NASDAQ:EQ). Over her 20+ years as a life science executive, her roles have spanned Clinical, Medical, Regulatory, Operations and Strategy
functional areas, and she has worked at both private and public companies. She has a strong preference for small and emerging companies where she can have a real impact on corporate strategy and external narrative, decision making processes to drive internal clarity and effectiveness, and in setting a work culture which is engaged, empowered, and inclusive. She helps companies scale in a stage appropriate manner focusing on best strategies for value creation. She holds an MD from the University of Pennsylvania and an MBA from the Wharton School of Business. She has been a member of Athena
since 2018, been selected for the 2019 Women in Bio Boardroom Ready cohort, and participated in Harvard’s executive education for Women on Life Science Boards.
An Athena team member will facilitate this event to provide an open space for casual dialogue and sharing.
Peer Group: Life Sciences Professionals
Mon, Oct 24 @ 2:00pm PT (1 hr)
Virtual (RSVP for link)
Peer Group
To access this event, choose one of the options below.
Already a member? Log in here.
Not a member? Join an event or two on a trial basis. Contact us at [email protected].
Join a powerhouse community of executive women and gain support in every aspect of your senior leadership career.
LEARN MOREInvest in your senior leadership career and join our global, virtual community of the most influential women in business.